2021
DOI: 10.1242/dmm.048983
|View full text |Cite
|
Sign up to set email alerts
|

(Dis)Solving the problem of aberrant protein states

Abstract: Neurodegenerative diseases and other protein-misfolding disorders represent a longstanding biomedical challenge, and effective therapies remain largely elusive. This failure is due, in part, to the recalcitrant and diverse nature of misfolded protein conformers. Recent work has uncovered that many aggregation-prone proteins can also undergo liquid–liquid phase separation, a process by which macromolecules self-associate to form dense condensates with liquid properties that are compositionally distinct from the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
35
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 26 publications
(37 citation statements)
references
References 84 publications
(145 reference statements)
0
35
0
Order By: Relevance
“…With the goal of generating a rationally designed, non-amyloidogenic variant of PNT3, we carried out a bioinformatic analysis. Taking into account the ability of prion-like domains (PLDs) (i.e., IDRs enriched in Asn and Gln residues) to drive fibrillation [38,41,[95][96][97][98], we first analyzed the PNT3 sequence using various PLD predictors including LPS, PAPA, PLAAC, and PrionW (see [99] and references therein cited). No PLD was found within the PNT3 sequence, indicating that the sequence determinants that drive the fibrillation of PNT3 are distinct from those of typical PLDs.…”
Section: Rational Design Of a Pnt3 Variant With A Hampered Ability To Form Amyloid-like Fibrilsmentioning
confidence: 99%
“…With the goal of generating a rationally designed, non-amyloidogenic variant of PNT3, we carried out a bioinformatic analysis. Taking into account the ability of prion-like domains (PLDs) (i.e., IDRs enriched in Asn and Gln residues) to drive fibrillation [38,41,[95][96][97][98], we first analyzed the PNT3 sequence using various PLD predictors including LPS, PAPA, PLAAC, and PrionW (see [99] and references therein cited). No PLD was found within the PNT3 sequence, indicating that the sequence determinants that drive the fibrillation of PNT3 are distinct from those of typical PLDs.…”
Section: Rational Design Of a Pnt3 Variant With A Hampered Ability To Form Amyloid-like Fibrilsmentioning
confidence: 99%
“…Upregulation of transcripts of both ATP-dependent and -independent HSP mRNAs (Fig. 4B, C) might implicate a cellular strategy wherein a cell can employ these proteins in clearing aggregates distinctly and more efficiently (Fare and Shorter, 2021); some of these genes may also be involved in long-term stress adaptation (Bijlsma and Loeschcke, 2005; De Bruijn, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…An activated disaggregase would promote this situation but, as reported for Hsp104, a strong activity could also unfold non-pathogenic proteins, and therefore be toxic, especially if the concentration of the target substrate protein(s) decreases [127]. It would also be desirable to enhance the activity of the specific chaperone-cochaperones combinations involved in the disaggregation of a specific substrate protein, a task that is far for being achieved for the human disaggregase and has started to be developed for Hsp104 [46,128]. This could be accomplished by engineering new chaperones/cochaperones that recognize certain substrates and/or by small molecules that favor specific interactions between the components of the disaggregase and activate the complex.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%